ArticleJournal of inflammation research2026
Association Between Systemic Immune-Inflammation Index and in-Hospital and Long-Term All-Cause Mortality in Patients with Type 2 Diabetes Mellitus Complicated by Spontaneous Intracerebral Hemorrhage.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Patients with type 2 diabetes mellitus (T2DM) and spontaneous intracerebral hemorrhage (sICH) face high mortality. Systemic inflammation may play a key role, but the prognostic value of the systemic immune-inflammation index (SII) in this population remains unclear. This study aimed to investigate the association between SII and all-cause mortality in T2DM with sICH. Methods: A retrospective cohort study was conducted on 891 patients with T2DM and sICH hospitalized at the First Affiliated Hospital of Harbin Medical University from January 2021 to December 2024. SII was calculated using the formula: platelet count × neutrophil count/lymphocyte count. Patients were categorized into high and low SII groups based on the median value (817.5). Kaplan-Meier survival analysis, multivariate logistic and Cox regression models were used to assess the association of SII with in-hospital and long-term mortality. Subgroup and sensitivity analyses were performed to test the robustness of findings. Receiver operating characteristic (ROC) curves further evaluated predictive performance. Results: In fully adjusted models, high SII was independently associated with a significantly increased risk of in-hospital mortality (OR = 3.122, 95% CI: 1.759-5.544, Conclusion: Elevated SII is an independent predictor of both in-hospital and long-term all-cause mortality in patients with T2DM and sICH. This may be because high SII reflects an imbalance of inflammation and immunity, leading to increased mortality risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.